Abeona Therapeutics (ABEO) Return on Invested Capital (2026)

Abeona Therapeutics (ABEO) recorded quarterly Return on Invested Capital of 0.0% in Q1 2026.

Abeona Therapeutics (ABEO) Return on Invested Capital (2026) Analysis & Trends

Abeona Therapeutics' Return on Invested Capital history runs 1 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • In Q1 2026, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
  • Return on Invested Capital was 0.0% for Q1 2026 at Abeona Therapeutics.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2026 to a low of 0.0% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.01%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -0.01%
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -0.01%
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 0.00%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Abeona Therapeutics 309.15 Mn 140.88 Mn 6.02 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%